Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2008.110593v1, 2008; 10.1373/clinchem.2008.110593
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2008.110593v1
54/12/1969    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nybo, M.
Right arrow Articles by Rasmussen, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nybo, M.
Right arrow Articles by Rasmussen, L. M.

Received on May 14, 2008
Accepted on August 21, 2008

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Lack of Observed Association between High Plasma Osteoprotegerin Concentrations and Ischemic Stroke Risk in a Healthy Population

Mads Nybo 1*, Søren P. Johnsen 2, Claus Dethlefsen 3, Kim Overvad 4, Anne Tjønneland 5, Jens Otto L. Jørgensen 6, Lars Melholt Rasmussen 1

1 Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Odense, Denmark
2 Department of Clinical Epidemiology, Aarhus University Hospital, Denmark
3 Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Denmark
4 Department of Clinical Epidemiology, Aarhus University Hospital, Denmark, Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Denmark, and Department of Cardiology, Aalborg Hospital, Aarhus University Hospital, Denmark
5 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
6 Institute of Experimental Clinical Research, Aarhus University Hospital, Denmark

* To whom correspondence should be addressed. E-mail: mads.nybo{at}ouh.regionsyddanmark.dk.

BACKGROUND: Several studies suggest that osteoprotegerin (OPG) concentrations may be associated with the risk of ischemic stroke, but no large prospective studies have been conducted. We conducted a nested case-control study within a large cohort to elucidate a possible relation.

METHODS: The study was done within a follow-up study including 57 053 men and women. Baseline data included OPG concentrations, lifestyle factors, and medical history. Median length of follow-up was 3.1 years. We assessed the relationship between OPG and stroke risk using conditional logistic regression to adjust for known risk factors (smoking, blood pressure, cholesterol, diabetes, body mass index, alcohol use, polyunsaturated fatty acids, and education).

RESULTS: We identified 254 cases with verified incident acute ischemic stroke and 254 age- and sex-matched controls. Median plasma OPG concentration among cases was 1.84 µg/L (25th–75th percentile 1.45–2.30 µg/L) compared with 1.87 µg/L (1.49–2.27 µg/L) in the control group. The adjusted odds ratio was 0.87 (95% CI 0.46–1.63) comparing participants in the highest quartile of OPG concentrations with those in the lowest quartile.

CONCLUSIONS: These findings provide no support for the hypothesis that plasma OPG concentrations are associated with an increased risk of ischemic stroke. This result could indicate a different pathogenic process in stroke development from that in ischemic heart disease, where OPG is a strong predictor.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Association for Clinical Chemistry.